Phil Skolnick
Sr. V.P. Research, CSO, Euthymics Bioscience, Inc.
Companies
- OPIANT PHARMACEUTICALS, INC.Chief Scientific Officer Feb 13, 2017 to Mar 3, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OPIANT PHARMACEUTICALS, INC.0 shares2Mar 2, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2023Returned to company 2,000 shares at $20.00 of OPIANT PHARMACEUTICALS, INC.2
- Mar 2, 2023Granted 2,000 shares of OPIANT PHARMACEUTICALS, INC.2
- Mar 2, 2023Returned to company 11,736 shares at $20.00 of OPIANT PHARMACEUTICALS, INC.2
- Mar 2, 2023Returned to company 9,812 shares at $20.00 of OPIANT PHARMACEUTICALS, INC.2
- Jan 27, 2023Sold 480 shares at $20.26 of OPIANT PHARMACEUTICALS, INC.3
- Jan 9, 2023Sold 369 shares at $20.20 of OPIANT PHARMACEUTICALS, INC.4
- Jan 5, 2023Sold 1,421 shares at $20.20 of OPIANT PHARMACEUTICALS, INC.5
- Jul 14, 2022Sold 627 shares at $11.85 of OPIANT PHARMACEUTICALS, INC.6
- Jun 27, 2022Granted 2,000 shares of OPIANT PHARMACEUTICALS, INC.7
- Jan 27, 2022Sold 1,518 shares at $26.19 of OPIANT PHARMACEUTICALS, INC.8
- Jan 10, 2022Sold 385 shares at $30.49 of OPIANT PHARMACEUTICALS, INC.9
- Jan 4, 2022Granted 12,000 shares of OPIANT PHARMACEUTICALS, INC.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 31, 2023
- 4SEC EDGARForm 4 filed Jan 9, 2023
- 5SEC EDGARForm 4 filed Jan 5, 2023
- 6SEC EDGARForm 4 filed Jul 15, 2022
- 7SEC EDGARForm 4 filed Jun 29, 2022
- 8SEC EDGARForm 4 filed Jan 27, 2022
- 9SEC EDGARForm 4 filed Jan 12, 2022
- 10SEC EDGARForm 4 filed Jan 5, 2022